FN2 Earnings Intelligence
Raymond James Financial, Inc. financials
Raymond James Financial, Inc. (RJF) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 est. | 9/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $7,201 | $6,178 | $9,313 | $10,998 | $11,389 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $9,910 | $11,308 | $12,992 | $14,923 | $15,912 | $15,749.9 | $17,557.8 |
| % Growth | 21.3% | 14.1% | 14.9% | 14.9% | 6.6% | -1.0% | 11.5% |
| Gross Profit | $1,941 | $2,327 | $3,653 | $4,745 | $4,561 | - | - |
| % Margin | 19.6% | 20.6% | 28.1% | 31.8% | 28.7% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $1,403 | $1,509 | $1,739 | $2,068 | $2,135 | - | - |
| % Margin | 14.2% | 13.3% | 13.4% | 13.9% | 13.4% | - | - |
| Diluted EPS | $6.63 | $6.98 | $7.97 | $9.70 | $10.30 | $12.15 | $14.27 |
| % Growth | 13.7% | 5.3% | 14.2% | 21.7% | 6.2% | 17.9% | 17.4% |
| Operating Cash Flow | $6,625 | $72 | -$3,514 | $2,155 | $2,434 | - | - |
| CapEx | $74 | $91 | $173 | $205 | $188 | - | - |
| Free Cash Flow | $6,551 | -$19 | -$3,687 | $1,950 | $2,246 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 | 9/30/2026 est. | 9/30/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $9,910 | $11,308 | $12,992 | $14,923 | $15,912 | $15,749.9 | $17,557.8 |
| Gross Profit | $1,941 | $2,327 | $3,653 | $4,745 | $4,561 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $1,403 | $1,509 | $1,739 | $2,068 | $2,135 | - | - |
| Diluted EPS | $6.63 | $6.98 | $7.97 | $9.70 | $10.30 | $12.15 | $14.27 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $7,201 | $6,178 | $9,313 | $10,998 | $11,389 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $2,037 | $2,038 | $2,039 | $2,040 | $3,520 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $6,625 | $72 | -$3,514 | $2,155 | $2,434 |
| Capital Expenditure | $74 | $91 | $173 | $205 | $188 |
| Free Cash Flow | $6,551 | -$19 | -$3,687 | $1,950 | $2,246 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2021 | 9/30/2022 | 9/30/2023 | 9/30/2024 | 9/30/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 21.3% | 14.1% | 14.9% | 14.9% | 6.6% |
| Gross Margin | 19.6% | 20.6% | 28.1% | 31.8% | 28.7% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 14.2% | 13.3% | 13.4% | 13.9% | 13.4% |
| FCF Margin | 66.1% | -0.2% | -28.4% | 13.1% | 14.1% |
| Diluted EPS Growth | 13.7% | 5.3% | 14.2% | 21.7% | 6.2% |